Amexdrug Corporation (AXRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 6, 2025
Amexdrug Revenue
Amexdrug had revenue of $2.15M in the quarter ending June 30, 2013, a decrease of -6.96%. This brings the company's revenue in the last twelve months to $9.17M, down -12.19% year-over-year. In the year 2012, Amexdrug had annual revenue of $9.15M, down -26.26%.
Revenue (ttm)
9.17M
Revenue Growth
-12.19%
P/S Ratio
0.00
Revenue / Employee
833.41K
Employees
11
Market Cap
16.91K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2012 | 9.15M | -3.26M | -26.26% |
Dec 31, 2011 | 12.41M | 919.39K | 8.00% |
Dec 31, 2010 | 11.49M | 1.72M | 17.61% |
Dec 31, 2009 | 9.77M | 4.07M | 71.55% |
Dec 31, 2008 | 5.69M | -446.13K | -7.27% |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Dec 31, 2004 | Pro | Pro | Pro |
Dec 31, 2003 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |